ebopotohy.wordpress.com
Biogen Idec creates new standards of care in therapeuti c areas with high unmet medical Foundedin 1978, Biogej Idec is a global leader in the development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countriexs benefit fromBiogen Idec's significant products that address diseasesa such as multiple sclerosis (MS), lymphomaa and rheumatoid arthritis. In 2008, Biogen Idec'w total revenues grew 29 percent over 2007to $4.
1 Currently, the company markets three major therapiew and its product development pipeline includes 20 product in Phase 2 clinical trials and Our major products include TYSABRo (natalizumab), the most recently approved treatment for relapsing formes of MS; AVONEX (Interferon beta-1a), the No. 1 prescribedd therapy for relapsing forms of MS andRITUXAN (rituximab), the world's most prescribed therapy for non-Hodgkin's lymphoma and marketede for the first time in 2006 for rheumatoid AVONEX and RITUXAN have for years ranked amongb the top 10 biotechnologty products sold globally.
In recent we also have leveraged our core capabilitiews to expand development into promising new therapeutic such as cardiovascular diseaseand hemophilia. Biogen Idec is headquarteredf in Cambridge, Massachusetts, with international headquartersin Zug, We have additional offices in the Canada, Australia, Japan and throughoutr Europe. ...
Subscribe to:
Post Comments (Atom)
Most people have wrong impression that Great company profile can engage and attract more customers. But there is need to ensure that it is listed on the front pages of the search engines to get more traffic.
ReplyDeleteSC Moda us profile